DE3521303A1 - 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten - Google Patents

4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Info

Publication number
DE3521303A1
DE3521303A1 DE19853521303 DE3521303A DE3521303A1 DE 3521303 A1 DE3521303 A1 DE 3521303A1 DE 19853521303 DE19853521303 DE 19853521303 DE 3521303 A DE3521303 A DE 3521303A DE 3521303 A1 DE3521303 A1 DE 3521303A1
Authority
DE
Germany
Prior art keywords
group
compound
formula
hydrogen
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19853521303
Other languages
German (de)
English (en)
Inventor
Roberto De Castiglione
Roberto Cimaschi
Ugo Arese Mailand/Milano Scarponi
Antonietta Mailand/Milano Verini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL filed Critical Farmitalia Carlo Erba SRL
Publication of DE3521303A1 publication Critical patent/DE3521303A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE19853521303 1985-01-22 1985-06-13 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten Withdrawn DE3521303A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858501542A GB8501542D0 (en) 1985-01-22 1985-01-22 4 5 6 7-tetrahydro-imidazo(4 5-clpyridine derivatives

Publications (1)

Publication Number Publication Date
DE3521303A1 true DE3521303A1 (de) 1985-10-31

Family

ID=10573211

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853521303 Withdrawn DE3521303A1 (de) 1985-01-22 1985-06-13 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten

Country Status (4)

Country Link
JP (1) JPS61167687A (ja)
BE (1) BE902611A (ja)
DE (1) DE3521303A1 (ja)
GB (2) GB8501542D0 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245637A1 (en) * 1986-04-01 1987-11-19 Warner-Lambert Company 4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine derivatives and analogs having antihypertensive activity
US7071355B2 (en) 2002-12-23 2006-07-04 4 Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816463A (en) * 1986-04-01 1989-03-28 Warner-Lambert Company Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
WO2000042023A1 (en) 1999-01-18 2000-07-20 Novo Nordisk A/S Substituted imidazoles, their preparation and use
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
AU2002214505A1 (en) * 2000-11-09 2002-05-21 Biovitrum Ab New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
US7247736B2 (en) 2002-12-23 2007-07-24 4Sc Ag Method of identifying inhibitors of DHODH
PL1706403T3 (pl) * 2003-12-22 2012-07-31 K U Leuven Res & Development Związki imidazo[4,5-c]pirydynowe i sposoby leczenia przeciwwirusowego
BRPI0513811A (pt) * 2004-07-27 2008-07-15 Gilead Sciences Inc imidazo [4,5-d] pirimidinas, seus usos e processos de preparação
DE602005013580D1 (de) 2004-12-21 2009-05-07 Leuven K U Res & Dev Imidazoä4,5-cüpyridinverbindung und verfahren zur antiviralen behandlung
TWI360549B (en) 2006-07-07 2012-03-21 Gilead Sciences Inc Novel pyridazine compound and use thereof
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
EP3322418A4 (en) * 2015-07-16 2019-02-13 Loma Linda University COMPOSITIONS FOR PREVENTING CANCER DISORDERS RELATED TO HUMAN PAPILLOMA VIRUSES
US10858366B2 (en) * 2016-03-08 2020-12-08 Novartis Ag Tricyclic compounds useful to treat orthomyxovirus infections
JOP20170169A1 (ar) 2016-08-29 2019-01-30 Novartis Ag مركبات بيريدازين ثلاثية الحلقة مندمجة تفيد في علاج العدوى بفيروس أورثوميكسو
KR20230031990A (ko) 2018-02-28 2023-03-07 노파르티스 아게 인플루엔자의 치료를 위한 오르토믹소바이러스 복제의 억제제로서의 10-(디(페닐)메틸)-4-히드록시-8,9,9a,10-테트라히드로-7h-피롤로[1',2':4,5]피라지노[1,2-b]피리다진-3,5-디온 유도체 및 관련 화합물

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245637A1 (en) * 1986-04-01 1987-11-19 Warner-Lambert Company 4,5,6,7-Tetrahydro-1H-imidazo[4,5-c]pyridine derivatives and analogs having antihypertensive activity
US7071355B2 (en) 2002-12-23 2006-07-04 4 Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
US7365094B2 (en) 2002-12-23 2008-04-29 4Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents

Also Published As

Publication number Publication date
GB8501542D0 (en) 1985-02-20
JPS61167687A (ja) 1986-07-29
GB8514278D0 (en) 1985-07-10
BE902611A (fr) 1985-09-30
GB2158440B (en) 1988-06-02
GB2158440A (en) 1985-11-13

Similar Documents

Publication Publication Date Title
DE3521303A1 (de) 4,5,6,7-tetrahydroimidazo(4,5- c)pyridinderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
EP0079022B1 (de) Derivate der cis, endo-2-Azabicyclo-(3.3.0)-octan-3-carbonsäure, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und deren Verwendung
AT390732B (de) Pharmazeutika enthaltend pyrazole
DE2255172A1 (de) Imidazotriazinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2706977A1 (de) Benzoesaeuren und deren derivate sowie verfahren zu ihrer herstellung
DE69722858T2 (de) Intimale verdickungsinhibitoren
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
CH671958A5 (ja)
WO2002022586A1 (de) Indazole mit thyroid-hormon-ähnlicher wirkung, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3031791C2 (ja)
DE2163601A1 (de) Arzneimittel mit einem Gehalt an (3,5,3,5-Tetraoxo)-1,2-dipiperazinoalkanverbindungen und Verfahren zur Herstellung der Verbindungen
DE2802630A1 (de) 6-ethoxy-1,2-dihydro-2,2,4-trimethylchinolinderivate und verfahren zu ihrer herstellung
DE3622036A1 (de) Benzimidazolderivate
EP0431371B1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
DD147110A5 (de) Verfahren zur herstellung von 9-eckige klammer auf 3-(3.5-cis-dimethylpiperazino)-propyl eckige klammer zu-carbazol und dessen salzen
DE2804519C2 (ja)
DE3049959C2 (ja)
EP0170861B1 (de) 3-Aminocarbonylmethoxy-5-phenylpyrazol-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2535599C2 (de) Substituierte Zimtsäureamide, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE2801478C2 (ja)
DD247448A5 (de) Verfahren zur herstellung neuer chinolinderivate
DE2305514A1 (de) Verfahren zur herstellung von lysergsaeureamiden und dihydrolysergsaeureamiden sowie lysergsaeureamide und dihydrolysergsaeureamide und ihre verwendung
EP0239667B1 (de) 5- oder 6-substituierte-beta-carbolin-3-carbonsäureester
DE3423003A1 (de) Benzo(c)(1,8)naphthyridine, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
DE3040085C2 (ja)

Legal Events

Date Code Title Description
OAV Applicant agreed to the publication of the unexamined application as to paragraph 31 lit. 2 z1
8141 Disposal/no request for examination